Please wait
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
January 5, 2023
Accession Number:
0001193125-23-000327
Submission Type:
POS AM
CIK:
0001720725
Company Name:
Oyster Point Pharma, Inc.
File Number:
333-249881